Top

Published in:

01-05-2015 | Review

Genetic variations underlying self-reported physical functioning: a review

Authors: Melissa S. Y. Thong, Mirjam A. G. Sprangers, Jeff A. Sloan, Donald L. Patrick, Ping Yang, Cornelis J. F. van Noorden

Published in: Quality of Life Research | Issue 5/2015

Abstract

Purpose

Genetic associations with self-reported physical functioning (SPF) are less well-studied than genetic associations with performance-measured physical functioning (PPF). We review the literature on the associations of genetic variations on SPF. We provide an overview of SPF assessment, genetic contributions to SPF including heritability, effects of genetic variations and mutations, and effects of interventions on the gene–SPF relationship. We also aim to provide directions for future research.

Methods

A computerized literature search using PubMed, Web of Science, and PsychInfo was conducted to select relevant literature published up to November 2013. Inclusion criteria were the use of an SPF questionnaire, original articles in English on human subjects, published in peer-reviewed journals and reporting significant associations between SPF and the genome.

Results

Nineteen articles were included. SPF was commonly assessed with the Short Form-36 questionnaire involving mainly convenience samples of either older persons or chronically ill. Heritability estimates were 10–30 %. Candidate genes associated with SPF could be ascribed to biological pathways associated with neurodegeneration, physiological systems regulation, or cell regulation. The APOE gene associated with neurodegeneration was most studied (n = 3). Three papers included both SPF and PPF assessments. No genome-wide association study on SPF has been conducted.

Conclusions

Associations between SPF and the genome have been investigated in selected populations in a limited number of publications. Future research should consider increasing sample variation and incorporate both SPF and PPF assessments. Also, longitudinal studies should be conducted in order to elicit stronger conclusions regarding the genetic associations with SPF.

Available only for authorised users

Fayers, P. M., & Machin, D. (2007). Quality of life: The assessment, analysis and interpretation of patient-reported outcomes (2nd ed.). Chichester: John Wiley & Sons Ltd.CrossRef

Bouchard, C. (2012). Genomic predictors of trainability. Experimental Physiology, 97(3), 347–352.CrossRefPubMed

Garatachea, N., & Lucia, A. (2013). Genes, physical fitness and ageing. Ageing Research Reviews, 12(1), 90–102.CrossRefPubMed

Rankinen, T., Perusse, L., Rauramaa, R., et al. (2001). The human gene map for performance and health-related fitness phenotypes. Medicine and Science in Sports and Exercise, 33(6), 855–867.CrossRefPubMed

Rankinen, T., Perusse, L., Rauramaa, R., et al. (2002). The human gene map for performance and health-related fitness phenotypes: The 2001 update. Medicine and Science in Sports and Exercise, 34(8), 1219–1233.CrossRefPubMed

Perusse, L., Rankinen, T., Rauramaa, R., et al. (2003). The human gene map for performance and health-related fitness phenotypes: The 2002 update. Medicine and Science in Sports and Exercise, 35(8), 1248–1264.CrossRefPubMed

Rankinen, T., Perusse, L., Rauramaa, R., et al. (2004). The human gene map for performance and health-related fitness phenotypes: The 2003 update. Medicine and Science in Sports and Exercise, 36(9), 1451–1469.CrossRefPubMed

Wolfarth, B., Bray, M. S., Hagberg, J. M., et al. (2005). The human gene map for performance and health-related fitness phenotypes: The 2004 update. Medicine and Science in Sports and Exercise, 37(6), 881–903.PubMed

Rankinen, T., Bray, M. S., Hagberg, J. M., et al. (2006). The human gene map for performance and health-related fitness phenotypes: The 2005 update. Medicine and Science in Sports and Exercise, 38(11), 1863–1888.CrossRefPubMed

10.

Bray, M. S., Hagberg, J. M., Perusse, L., et al. (2009). The human gene map for performance and health-related fitness phenotypes: The 2006–2007 update. Medicine and Science in Sports and Exercise, 41(1), 35–73.CrossRefPubMed

11.

Rankinen, T., Roth, S. M., Bray, M. S., et al. (2010). Advances in exercise, fitness, and performance genomics. Medicine and Science in Sports and Exercise, 42(5), 835–846.CrossRefPubMed

12.

Hagberg, J. M., Rankinen, T., Loos, R. J., et al. (2011). Advances in exercise, fitness, and performance genomics in 2010. Medicine and Science in Sports and Exercise, 43(5), 743–752.CrossRefPubMedCentralPubMed

13.

Roth, S. M., Rankinen, T., Hagberg, J. M., et al. (2012). Advances in exercise, fitness, and performance genomics in 2011. Medicine and Science in Sports and Exercise, 44(5), 809–817.CrossRefPubMedCentralPubMed

14.

Perusse, L., Rankinen, T., Hagberg, J. M., et al. (2013). Advances in exercise, fitness, and performance genomics in 2012. Medicine and Science in Sports and Exercise, 45(5), 824–831.CrossRefPubMedCentralPubMed

15.

Sprangers, M. A., Sloan, J. A., Veenhoven, R., et al. (2009). The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Research and Human Genetics, 12(3), 301–311.CrossRefPubMedCentralPubMed

16.

Sprangers, M. A., Sloan, J. A., Barsevick, A., et al. (2010). Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research, 19(10), 1395–1403.CrossRefPubMedCentralPubMed

17.

Ordonana, J. R., Bartels, M., Boomsma, D. I., et al. (2012). Biological pathways and genetic mechanisms involved in social functioning. Quality of Life Research, 22(6), 1189–1200.CrossRefPubMed

18.

Sprangers, M. A., Bartels, M., Veenhoven, R., et al. (2010). Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Quality of Life Research, 19(10), 1429–1437.CrossRefPubMedCentralPubMed

19.

Barsevick, A., Frost, M., Zwinderman, A., et al. (2010). I’m so tired: Biological and genetic mechanisms of cancer-related fatigue. Quality of Life Research, 19(10), 1419–1427.CrossRefPubMedCentralPubMed

20.

Shi, Q., Cleeland, C. S., Klepstad, P., et al. (2010). Biological pathways and genetic variables involved in pain. Quality of Life Research, 19(10), 1407–1417.CrossRefPubMed

21.

Sprangers, M. A. G., Thong, M. S. Y., Bartels, M., et al. (2014). Biological pathways, candidate genes, and molecular markers associated with quality-of-life- domains: An update. Quality of Life Research, 23(7), 1997–2013.

22.

Shin, S. Y. (2012). The relationship between cognitive and physical function in older adults with rheumatoid arthritis: A literature review. Journal of Gerontological Nursing, 38(9), 33–42.CrossRefPubMed

23.

McGue, M., & Christensen, K. (2007). Social activity and healthy aging: a study of aging Danish twins. Twin Research and Human Genetics, 10(2), 255–265.CrossRefPubMed

24.

Bussmann, J. B., Garssen, M. P., van Doorn, P. A., et al. (2007). Analysing the favourable effects of physical exercise: Relationships between physical fitness, fatigue and functioning in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Journal of Rehabilitation Medicine, 39(2), 121–125.CrossRefPubMed

25.

Rejeski, W. J., King, A. C., Katula, J. A., et al. (2008). Physical activity in prefrail older adults: Confidence and satisfaction related to physical function. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 63(1), P19–P26.CrossRef

26.

Peng, Y. S., Chiang, C. K., Hung, K. Y., et al. (2010). Are both psychological and physical dimensions in health-related quality of life associated with mortality in hemodialysis patients: A 7-year Taiwan cohort study. Blood Purification, 30(2), 98–105.CrossRefPubMed

27.

Yi, J., Kim, M. A., & Tian, T. (2014). Perceived long-term and physical health problems after cancer: Adolescent and young adult survivors of childhood cancer in Korea. European Journal of Oncology Nursing, 18(2), 145–150.CrossRefPubMed

28.

van Velzen, G. A. J., Perez, R. S. G. M., van Gestel, M. A., et al. Health-related quality of life in 975 patients with complex regional pain syndrome type 1. Pain, 155(3), 629–634.

29.

De Buyser, S. L., Petrovic, M., Taes, Y. E., et al. (2013). Physical function measurements predict mortality in ambulatory older men. European Journal of Clinical Investigation, 43(4), 379–386.CrossRefPubMed

30.

Tager, I. B., Haight, T. J., Hollenberg, M., et al. (2003). Physical functioning and mortality in older women: An assessment of energy costs and level of difficulty. Journal of Clinical Epidemiology, 56(8), 807–813.CrossRefPubMed

31.

Ware, J., Jr. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center.

32.

Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in Oncology. Journal of the National Cancer Institute, 85(5), 365–376.CrossRefPubMed

33.

McColl, E., & Fayers, P. M. (2005). Context effects and proxy assessments. In P. M. Fayers & R. D. Hays (Eds.), Assessing quality of life in clinical trials (pp. 131–146). New York: Oxford University Press.

34.

Mahoney, F. I., & Barthel, D. W. (1965). Functional evaluation: The Barthel Index. Maryland State Medical Journal, 14, 61–65.PubMed

35.

Katz, S., Ford, A. B., Moskowitz, R. W., et al. (1963). Studies of illness in the aged: The Index of ADL: A standardized measure of biological and psychosocial function. JAMA, 185(12), 914–919.CrossRefPubMed

36.

Sprangers, M. A., & Aaronson, N. K. (1992). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. Journal of Clinical Epidemiology, 45(7), 743–760.CrossRefPubMed

37.

Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65.CrossRefPubMed

38.

Romeis, J. C., Heath, A. C., Xian, H., et al. (2005). Heritability of SF-36 among middle-age, middle-class, male-male twins. Medical Care, 43(11), 1147–1154.CrossRefPubMed

39.

Christensen, K., Frederiksen, H., Vaupel, J. W., et al. (2003). Age trajectories of genetic variance in physical functioning: A longitudinal study of Danish twins aged 70 years and older. Behavior Genetics, 33(2), 125–136.CrossRefPubMed

40.

Dato, S., Montesanto, A., Lagani, V., et al. (2012). Frailty phenotypes in the elderly based on cluster analysis: A longitudinal study of two Danish cohorts. Evidence for a genetic influence on frailty. Age, 34(3), 571–582.CrossRefPubMedCentralPubMed

41.

Bookheimer, S., & Burggren, A. (2009). APOE-4 genotype and neurophysiological vulnerability to Alzheimer’s and cognitive aging. Annual Review of Clinical Psychology, 5(1), 343–362.CrossRefPubMedCentralPubMed

42.

Carmelli, D., DeCarli, C., Swan, G. E., et al. (2000). The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 55(2), M103–M109.CrossRefPubMed

43.

Carmelli, D., Reed, T., & DeCarli, C. (2002). A bivariate genetic analysis of cerebral white matter hyperintensities and cognitive performance in elderly male twins. Neurobiology of Aging, 23(3), 413–420.CrossRefPubMed

44.

Snejdrlova, M., Kalvach, Z., Topinkova, E., et al. (2011). APOE polymorphism as a potential determinant of functional fitness in the elderly regardless of nutritional status. Neuroendocrinology Letters, 32(Suppl 2), 51–54.PubMed

45.

Fillenbaum, G. (1988). Multidimensional functional assessment of older adults: The Duke older Americans resources and services procedures. Hillsdale, NJ: Erlbaum.

46.

Rosow, I., & Breslau, N. (1966). A Guttman health scale for the aged. Journal of Gerontology, 21(4), 556–559.CrossRefPubMed

47.

Blazer, D. G., Fillenbaum, G., & Burchett, B. (2001). The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 56(12), M785–M789.CrossRef

48.

Gallagher-Thompson, D., O’Hara, R., Simmons, A., et al. (2001). Apolipoprotein E epsilon4 allele affects the relationship between stress and depression in caregivers of patients with Alzheimer’s disease. Journal of Geriatric Psychiatry and Neurology, 14(3), 115–119.CrossRefPubMed

49.

Daly, M., & MacLachlan, M. (2011). Heredity links natural hazards and human health: Apolipoprotein E gene moderates the health of earthquake survivors. Health Psychology, 30(2), 228–235.CrossRefPubMed

50.

Coelho, F. G., Gobbi, S., Andreatto, C. A., et al. (2013). Physical exercise modulates peripheral levels of brain-derived neurotrophic factor (BDNF): A systematic review of experimental studies in the elderly. Archives of Gerontology and Geriatrics, 56(1), 10–15.CrossRefPubMed

51.

Sakuma, K., Yamaguchi, A. (2011). The recent understanding of the neurotrophin’s role in skeletal muscle adaptation. Journal of Biomedicine and Biotechnology, 2011, 201696.

52.

Kim, J. M., Stewart, R., Park, M. S., et al. (2012). Associations of BDNF genotype and promoter methylation with acute and long-term stroke outcomes in an East Asian cohort. PLoS ONE, 7(12), e51280.CrossRefPubMedCentralPubMed

53.

Kadmiel, M., & Cidlowski, J. A. (2013). Glucocorticoid receptor signaling in health and disease. Trends in Pharmacological Sciences, 34(9), 518–530.CrossRefPubMedCentralPubMed

54.

Kuo, T., Harris, C. A., & Wang, J. C. (2013). Metabolic functions of glucocorticoid receptor in skeletal muscle. Molecular and Cellular Endocrinology, 380(1–2), 79–88.CrossRefPubMed

55.

Hauer, D., Weis, F., Papassotiropoulos, A., et al. (2011). Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Critical Care Medicine, 39(4), 643–650.CrossRefPubMed

56.

Flato, B., Hoffmann-Vold, A. M., Reiff, A., et al. (2006). Long-term outcome and prognostic factors in enthesitis-related arthritis: A case-control study. Arthritis and Rheumatism, 54(11), 3573–3582.CrossRefPubMed

57.

McNearney, T. A., Hunnicutt, S. E., Fischbach, M., et al. (2009). Perceived functioning has ethnic-specific associations in systemic sclerosis: Another dimension of personalized medicine. The Journal of Rheumatology, 36(12), 2724–2732.CrossRefPubMedCentralPubMed

58.

Degens, H. (2010). The role of systemic inflammation in age-related muscle weakness and wasting. Scandinavian Journal of Medicine and Science in Sports, 20(1), 28–38.CrossRefPubMed

59.

Rausch, S. M., Clark, M. M., Patten, C., et al. (2010). Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer, 116(17), 4103–4113.CrossRefPubMedCentralPubMed

60.

Tiainen, K., Thinggaard, M., Jylha, M., et al. (2012). Associations between inflammatory markers, candidate polymorphisms and physical performance in older Danish twins. Experimental Gerontology, 47(1), 109–115.CrossRefPubMedCentralPubMed

61.

Ettinger, W. H, Jr, Burns, R., Messier, S. P., et al. (1997). A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA, 277(1), 25–31.CrossRefPubMed

62.

Nicklas, B. J., Mychaleckyj, J., Kritchevsky, S., et al. (2005). Physical function and its response to exercise: Associations with cytokine gene variation in older adults with knee osteoarthritis. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60(10), 1292–1298.CrossRef

63.

Rieder, M. J., Taylor, S. L., Clark, A. G., et al. (1999). Sequence variation in the human angiotensin converting enzyme. Nature Genetics, 22(1), 59–62.CrossRefPubMed

64.

Puthucheary, Z., Skipworth, J. R., Rawal, J., et al. (2011). The ACE gene and human performance: 12 years on. Sports Medicine, 41(6), 433–448.CrossRefPubMed

65.

Frederiksen, H., & Christensen, K. (2003). The influence of genetic factors on physical functioning and exercise in second half of life. Scandinavian Journal of Medicine and Science in Sports, 13(1), 9–18.CrossRefPubMed

66.

Chiu, L. L., Chen, T. W., Hsieh, S. S., et al. (2012). ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls. The Journal of Physiological Sciences, 62(2), 115–121.CrossRefPubMed

67.

Yoshihara, A., Tobina, T., Yamaga, T., et al. (2009). Physical function is weakly associated with angiotensin-converting enzyme gene I/D polymorphism in elderly Japanese subjects. Gerontology, 55(4), 387–392.CrossRefPubMed

68.

Frederiksen, H., Bathum, L., Worm, C., et al. (2003). ACE genotype and physical training effects: A randomized study among elderly Danes. Aging Clinical and Experimental Research, 15(4), 284–291.CrossRefPubMed

69.

Ferreira-Valente, M. A., Pais-Ribeiro, J. L., & Jensen, M. P. (2014). Associations between psychosocial factors and pain intensity, physical functioning, and psychological functioning in patients with chronic pain: A cross-cultural comparison. The Clinical Journal of Pain, 30(8), 713–723.CrossRefPubMed

70.

Petri, M., Kawata, A. K., Fernandes, A. W., et al. (2013). Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus. The Journal of Rheumatology, 40(11), 1865–1874.CrossRefPubMed

71.

Van Steenwinckel, J., Brisorgueil, M.-J., Fischer, J., et al. (2008). Role of spinal serotonin 5-HT2A receptor in 2′,3′-dideoxycytidine-induced neuropathic pain in the rat and the mouse. Pain, 137(1), 66–80.CrossRefPubMed

72.

Lebe, M., Hasenbring, M. I., Schmieder, K., et al. (2013). Association of serotonin-1A and -2A receptor promoter polymorphisms with depressive symptoms, functional recovery, and pain in patients 6 months after lumbar disc surgery. Pain, 154(3), 377–384.CrossRefPubMed

73.

Hopman, W. M., Harrison, M. B., Coo, H., et al. (2009). Associations between chronic disease, age and physical and mental health status. Chronic Diseases in Canada, 29(3), 108–116.PubMed

74.

Joseph, A.-M., Adhihetty, P. J., Buford, T. W., et al. (2012). The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high-and low-functioning elderly individuals. Aging Cell, 11(5), 801–809.CrossRefPubMedCentralPubMed

75.

Marzetti, E., Calvani, R., Bernabei, R., et al. (2012). Apoptosis in skeletal myocytes: A potential target for interventions against sarcopenia and physical frailty—A mini-review. Gerontology, 58(2), 99–106.CrossRefPubMed

76.

Ben-Porath, I., & Weinberg, R. A. (2005). The signals and pathways activating cellular senescence. The International Journal Of Biochemistry & Cell Biology, 37(5), 961–976.CrossRef

77.

Jeyapalan, J. C., & Sedivy, J. M. (2008). Cellular senescence and organismal aging. Mechanisms of Ageing and Development, 129(7–8), 467–474.CrossRefPubMedCentralPubMed

78.

Melzer, D., Frayling, T. M., Murray, A., et al. (2007). A common variant of the p16(INK4a) genetic region is associated with physical function in older people. Mechanisms of Ageing and Development, 128(5–6), 370–377.CrossRefPubMedCentralPubMed

79.

Nagi, S. Z. (1976). An epidemiology of disability among adults in the United States. The Milbank Memorial Fund Quarterly. Health and Society, 54(4), 439–467.CrossRefPubMed

80.

Brega, A. G., Reynolds, A., Bennett, R. E., et al. (2009). Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS). International Journal of Geriatric Psychiatry, 24(10), 1101–1109.CrossRefPubMed

81.

Van Acker, R. (1991). Rett syndrome: A review of current knowledge. Journal of Autism and Developmental Disorders, 21(4), 381–406.CrossRefPubMed

82.

Bienvenu, T., Carrié, A., de Roux, N., et al. (2000). MECP2 mutations account for most cases of typical forms of Rett syndrome. Human Molecular Genetics, 9(9), 1377–1384.CrossRefPubMed

83.

Landgraf, J. M. (1999). The Child Health Questionnaire (CHQ): A potential new tool to assess the outcome of psychosocial treatment and care. In M. E. Maruish (Ed.), The use of psychological testing for treatment planning and outcomes assessment (2nd ed., pp. 665–677). New Jersey: Lawrence Erlbaum Associates Publishers.

84.

Lane, J. B., Lee, H. S., Smith, L. W., et al. (2011). Clinical severity and quality of life in children and adolescents with Rett syndrome. Neurology, 77(20), 1812–1818.CrossRefPubMedCentralPubMed

85.

Letteboer, T. G., Zewald, R. A., Kamping, E. J., et al. (2005). Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. Human Genetics, 116(1–2), 8–16.CrossRefPubMed

86.

Pfister, M., Zalaman, I. M., Blumenstock, G., et al. (2009). Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Acta Oto-Laryngologica, 129(8), 862–866.CrossRefPubMed

87.

Lin, A. Y., Buckley, N. S., Lu, A.-T. T., et al. (2011). Effect of KRAS mutational status in advanced colorectal cancer on the outcomes of anti-epidermal growth factor receptor monoclonal antibody therapy: A systematic review and meta-analysis. Clinical Colorectal Cancer, 10(1), 63–69.CrossRefPubMed

88.

Baldus, S. E., Schaefer, K.-L., Engers, R., et al. (2010). Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clinical Cancer Research, 16(3), 790–799.CrossRefPubMed

89.

Au, H. J., Karapetis, C. S., O’Callaghan, C. J., et al. (2009). Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: Overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial. Journal of Clinical Oncology, 27(11), 1822–1828.CrossRefPubMed

90.

Yang, P., Ebbert, J. O., Sun, Z., et al. (2006). Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review. Journal of Clinical Oncology, 24(11), 1761–1769.CrossRefPubMed

91.

Yang, P., Yokomizo, A., Tazelaar, H. D., et al. (2002). Genetic determinants of lung cancer short-term survival: The role of glutathione-related genes. Lung Cancer, 35(3), 221–229.CrossRefPubMed

92.

Yang, P., Mandrekar, S. J., Hillman, S. H., et al. (2009). Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: An NCCTG-97-24-51 based study. Journal of Thoracic Oncology, 4(4), 479–485.CrossRefPubMedCentralPubMed

93.

Cella, D. F., Bonomi, A. E., Lloyd, S. R., et al. (1995). Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality of life instrument. Lung Cancer, 12(3), 199–220.CrossRefPubMed

94.

Bonnefont, J. P., Bastin, J., Laforet, P., et al. (2010). Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clinical Pharmacology and Therapeutics, 88(1), 101–108.CrossRefPubMed

95.

Djouadi, F., Bonnefont, J. P., Thuillier, L., et al. (2003). Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate. Pediatric Research, 54(4), 446–451.CrossRefPubMed

96.

Ortlepp, J. R., Metrikat, J., Vesper, K., et al. (2003). The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers. Journal of Molecular Medicine, 81(9), 578–584.CrossRefPubMed

97.

Nicklas, B. J. (2010). Heterogeneity of physical function responses to exercise in older adults: possible contribution of variation in the angiotensin-1 converting enzyme (ACE) gene? Perspectives on Psychological Science, 5(5), 575–584.CrossRef

98.

Bouchard, C., Sarzynski, M. A., Rice, T. K., et al. (2011). Genomic predictors of the maximal O(2) uptake response to standardized exercise training programs. Journal of Applied Physiology, 110(5), 1160–1170.CrossRefPubMedCentralPubMed

99.

Fredheim, O. M. S., Borchgrevink, P. C., Saltnes, T., et al. (2007). Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. Journal of Pain and Symptom Management, 34(6), 657–665.CrossRefPubMed

100.

Cieza, A., & Stucki, G. (2005). Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Quality of Life Research, 14(5), 1225–1237.CrossRefPubMed

Title: Genetic variations underlying self-reported physical functioning: a review
Authors: Melissa S. Y. Thong
Mirjam A. G. Sprangers
Jeff A. Sloan
Donald L. Patrick
Ping Yang
Cornelis J. F. van Noorden
Publication date: 01-05-2015
Publisher: Springer International Publishing
Published in: Quality of Life Research / Issue 5/2015
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-014-0844-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Genetic variations underlying self-reported physical functioning: a review

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2015

Evaluation of cross-cultural adaptation and measurement properties of breast cancer-specific quality-of-life questionnaires: a systematic review

Beyond lip service and box ticking: how effective patient engagement is integral to the development and delivery of patient-reported outcomes

Conceptual and practical foundations of patient engagement in research at the patient-centered outcomes research institute

Low-income minority patient engagement with automated telephonic depression assessment and impact on health outcomes

Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention

Engaging stakeholders to develop a depression management decision support tool in a tribal health system